$MIRM 3 SEC Filings

Filed On	Filing
22 Sep 2026	Form 3: Myers Robert Paul, Chief Medical Officer Holds 55 shares of Common Stock
18 Jan 2024	Form 3: Quan Joanne, CHIEF MEDICAL OFFICER No securities owned
12 Sep 2023	Form 3: Bjerkholt Eric, Chief Financial Officer No securities owned
09 May 2023	Form 3: Howe Jolanda, SVP, Global Controller Holds 1,769 shares of Common Stock
06 Apr 2023	Form 3: Walbert Timothy P, Director No securities owned
19 Dec 2022	Form 3: Cardon Lon, Director No securities owned
07 Jun 2022	Form 3: Ramasastry Saira, Director
20 Aug 2021	Form 3: Fairey William, Director No securities owned
08 Jun 2021	Form 3: Brosgart Carol L, Director No securities owned
30 Apr 2020	Form 3: Radovich Peter, Chief Operating Officer Holds 2,645 shares of Common Stock
28 Oct 2019	Form 3: Tucker Edwin Jonathan, Chief Medical Officer Holds 1,500 shares of Common Stock
17 Jul 2019	Form 3: Flynn James E, 10% owner and 5 others
17 Jul 2019	Form 3: Takeda Pharmaceutical Co Ltd, 10% owner and 1 other Holds 1,859,151 shares of Common Stock
17 Jul 2019	Form 3: Frazier Life Sciences IX, L.p., 10% owner and 3 others
17 Jul 2019	Form 3: Brege Laura, Director No securities owned
17 Jul 2019	Form 3: Fischer Laurent, Director
17 Jul 2019	Form 3: O'Donnell Niall, Director Holds 125,000 shares of Common Stock
17 Jul 2019	Form 3: Heron Patrick J, Director
17 Jul 2019	Form 3: Aynechi Tiba, Director No securities owned
17 Jul 2019	Form 3: Mott David M, 10% owner

Comments